Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-30

Clinical Trial Update: Cryoablation of Low Risk Small Breast Cancer- ICE3 Trial [NA]

View source ↗

Summary

The ICE3 trial evaluating cryoablation for low-risk small breast cancer has completed and results were posted in April 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IceCure Cryoablation System (cryoablation device)

Snippet

Sponsor: IceCure Medical Ltd. | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2025-04-30